Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Jan 2023. Module: SNOMED CT United Kingdom Edition module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2065571000001114 | Icosapent ethyl | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2065581000001111 | Icosapent ethyl (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Icosapent ethyl | Is a | N-3 fatty acid | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Adverse reaction to icosapent ethyl | Causative agent | True | Icosapent ethyl | Inferred relationship | Existential restriction modifier | 1 |
| Icosapent 998mg capsules | Has specific active ingredient | True | Icosapent ethyl | Inferred relationship | Existential restriction modifier | |
| Icosapent 998mg capsules 120 capsule | Has specific active ingredient | True | Icosapent ethyl | Inferred relationship | Existential restriction modifier | |
| Vazkepa 998mg capsules (Amarin Pharmaceuticals Ireland Ltd) 120 capsule | Has specific active ingredient | True | Icosapent ethyl | Inferred relationship | Existential restriction modifier | |
| Vazkepa 998mg capsules (Amarin Pharmaceuticals Ireland Ltd) | Has specific active ingredient | True | Icosapent ethyl | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR